Guy McKhann, M.D.
Guy McKhann, M.D., the scientific advisor to the Dana Foundation, studies the delineation of the neurological outcomes following coronary artery bypass grafting and the elucidation of the mechanism of a form of Guillen Barre Syndrome. He has also been active in defining the criteria for Alzheimer’s disease. McKhann attended Harvard University, and obtained his doctoral degree from Yale Medical School. After working at the National Institute of Neurological Disorders and Stroke, he took his residency in pediatric neurology at Massachusetts General Hospital. His first academic position was at Stanford University, where he founded the Pediatric Neurology service. He then moved to Johns Hopkins University Medical Center, where he was the first director of the neurology department.
What Bilingual Has Meant to MeViewpoint
Does being bilingual help preserve cognition? Our columnist, in his 80s now, thinks so, and is a believer in the adage, "Use it or lose it."
The world of neuroscience lost one of its pioneers when Vernon B. Mountcastle, M.D., died January 11 in Baltimore at age 96. Here are remembrances from two colleagues influenced by Mountcastle—among the many who have gone on to make their own significant impacts in neuroscience.
A Neurologist Looks Ahead to 2025
Pioneering neurologist Guy McKhann looks at how our understanding of the brain, and the capabilities of neurology, have changed over a quarter of a century.
Brain Death in an Age of Heroic Medicine
When the technology of heart transplantation and life-support machines overtook the traditionally accepted criterion of death—cessation of heartbeat—an alternative criterion emerged. Irreversible loss of brain function, or “brain death,” for all the debates and recent attacks it has provoked, has worked well as a determinant of death, argues Dr. Guy McKhann.